LBT Innovations Limited Share Price

Equities

LBT

AU000000LBT8

Biotechnology & Medical Research

Delayed Australian S.E. 07:01:21 29/04/2024 am IST 5-day change 1st Jan Change
0.022 AUD +10.00% Intraday chart for LBT Innovations Limited +10.00% +100.00%

Financials

Sales 2022 2.13M 1.4M 116M Sales 2023 2.13M 1.4M 117M Capitalization 10.37M 6.8M 567M
Net income 2022 -6M -3.94M -328M Net income 2023 -22M -14.43M -1.2B EV / Sales 2022 12.4 x
Net Debt 2022 1.5M 983K 81.93M Net Debt 2023 1.37M 897K 74.72M EV / Sales 2023 5.51 x
P/E ratio 2022
-3.58 x
P/E ratio 2023
-0.44 x
Employees 19
Yield 2022 *
-
Yield 2023
-
Free-Float 62.9%
More Fundamentals * Assessed data
Dynamic Chart
1 day+10.00%
1 week+10.00%
Current month-8.33%
1 month-15.38%
3 months+46.67%
6 months+340.00%
Current year+100.00%
More quotes
1 week
0.02
Extreme 0.019
0.02
1 month
0.02
Extreme 0.019
0.03
Current year
0.01
Extreme 0.009
0.04
1 year
0.00
Extreme 0.004
0.04
3 years
0.00
Extreme 0.004
0.16
5 years
0.00
Extreme 0.004
0.25
10 years
0.00
Extreme 0.004
1.09
More quotes
Managers TitleAgeSince
Chief Executive Officer - 08/16/08
Director of Finance/CFO - 25/17/25
Chief Tech/Sci/R&D Officer - 01/17/01
Members of the board TitleAgeSince
Director of Finance/CFO - 25/14/25
Chief Executive Officer - 08/16/08
Chairman - 01/23/01
More insiders
Date Price Change Volume
29/24/29 0.022 +10.00% 4 304 925
26/24/26 0.02 +5.26% 68,000
24/24/24 0.019 -5.00% 937,939
23/24/23 0.02 0.00% 1,888,949
22/24/22 0.02 0.00% 1,515,896

Delayed Quote Australian S.E., April 29, 2024 at 07:01 am IST

More quotes
LBT Innovations Limited is a medical technology company. The Company is engaged in researching, developing and commercializing technologies for the healthcare and laboratory supply markets and manufacture and sales of the Automated Plate Assessment System (APAS Independence). Its products include APAS Independence, APAS Analysis Modules, APAS-AMR Analysis Module, and APAS PharmaQ. The APAS Independence is a platform technology that automates culture-plate screening and interpretation. The APAS Analysis Modules are the intelligent image analysis software that works together with the APAS Independence to enable the screening of microbiology culture plates. The APAS-AMR Analysis Module uses artificial intelligence mage analysis platform to read and interpret antimicrobial susceptibility tests (ASTs) for the detection of antimicrobial resistance (AMR). The APAS PharmaQC provides automated imaging, analysis and interpretation of microbiology culture plates used in environmental monitoring.
More about the company